KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Case Report
Herpes zoster after COVID-19 disease
COVID-19 infection can affect immune system functions. Although age is seen as a major factor for the development of Herpes Zoster (HZ), immunosuppression or disease-related immune system dysfunction can progress with the reactivation of Varicella Zoster Virus (VZV). A 57-year-old male patient presented with painful lesions on his body after COVID-19 infection and was diagnosed with HZ. The patient was admitted to the algology outpatient clinic due to Postherpetic Neuralgia (PHN) 4 months after the onset of the rash. Our aim is to draw attention to the possibility of HZ and PHN development after COVID-19 infection.


1. Diez-Domingo J, Parikh R, Bhavsar AB, Cisneros E, McCormick N,Lecrenier N. Can COVID-19 increase the risk of herpes zoster? a narrativereview. Dermatol Ther (Heidelb) 2021; 11: 1119-26.
2. Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli DRB,Martelli-Júnior H. Increased number of herpes zoster cases in Brazilrelated to the COVID-19 pandemic. Int J Infect Dis 2021 Mar; 104: 732-3.
3. Saati A, Al-Husayni F, Malibari AA, Bogari AA, Alharbi M. Herpes zosterco-infection in an immunocompetent patient with COVID-19. Cureus2020; 12: e8998.
4. Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpeticneuralgia: prevention and management. Am Fam Physician 2017; 96: 656-63.
5. Saleh W, Ata F, Elashry MM. Is COVID-19 infection triggering oralherpes zoster? A case report. SAGE Open Med Case Rep 2021; 9:2050313X211065793.
6. Elsaie ML, Youssef EA, Nada HA. Herpes zoster might be an indicator forlatent COVID-19 infection. Dermatol Ther 2020; 33: e13666.
7. Ghosh B, Gajjar RA, Modi VK, Jadeja DM. A rare case of herpes zoster inan adult patient recovered from symptomatic reinfection of COVID-19.Cureus 2021; 13: e16274.
8. Puri P, Parnami P, Athwal PSS, Kumari S, Kumar C, Suri Y. COVID-19rekindling Herpes zoster in an immunocompetent patient. Cureus 2021;13: e18049.
9. Cao X, Zhang X, Meng W, Zheng H. Herpes zoster and postherpeticneuralgia in an elderly patient with critical COVID-19: a case report. JPain Res 2020; 13: 2361-5.
10. Laklouk M, Baranidharan G. Profile of the capsaicin 8% patch for themanagement of neuropathic pain associated with postherpetic neuralgia:safety, efficacy, and patient acceptability. Patient Prefer Adherence 2016;10: 1913-8.
11. Attal N, Martinez V, Bouhassira D. Potential for increased prevalence ofneuropathic pain after the COVID-19 pandemic. Pain Rep 2021; 6: e884.
12. Tulgar S, Selvi O, Senturk O, Serifsoy TE, Thomas DT. Ultrasound-guidederector spinae plane block: indications, complications, and effects on acuteand chronic pain based on a single-center experience. Cureus 2019; 11:e3815.
13. Aydın T, Balaban O, Ahiskalioglu A, Alici HA, Acar A. Ultrasound-guidederector spinae plane block for the management of herpes zoster pain:observational study. Cureus 2019; 11: e5891.
14. Gundoğdu Z, Özkan Z, Gundoğdu T. Ultrasound guided erector spinaeplane block in thoracıc herpes zoster related pain management. JCukurova Anesth Surg 2020: 3: 6-10.
Volume 2, Issue 4, 2022
Page : 138-140
_Footer